Samuel Broder

Insider Reports History

Entity
Individual
Location
C/O Sensei Biotherapeutics, Inc., 1405 Research Dr., Ste. 125, Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Broder:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Director Common Stock 8.93K $7.59K $0.85 Jul 10, 2023 Direct
Sensei Biotherapeutics, Inc. Director Stock Option (Right to Buy) 14.6K Jul 10, 2023 Direct
Orion Biotech Opportunities Corp. Director Class B ordinary shares 0 May 17, 2023 Direct

Insider Reports Filed by Samuel Broder

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNSE Sensei Biotherapeutics, Inc. Jul 10, 2023 2 $0 4 Jul 12, 2023 Director
ORIA Orion Biotech Opportunities Corp. May 17, 2023 1 $0 4 May 18, 2023 Director
SNSE Sensei Biotherapeutics, Inc. Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
ORIA Orion Biotech Opportunities Corp. May 12, 2021 0 $0 3 May 12, 2021 Director